InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: ststephensrevenge post# 190772

Thursday, 09/18/2014 12:35:50 PM

Thursday, September 18, 2014 12:35:50 PM

Post# of 346105

++++It is the craziest phenomenom.



My faith in Peregrine grows by the post, when I read such posts.

From stressed cells to cancer to hundreds of autoimmune diseases, to Bavi crops or lets say Crop Science as Bayer likes to call that division, to polymer plastics to chemical reactions to Electron Beam Processing... I truly am beginning to see a BASF type company of the future.

PS Targeting is in play

Peregrine knows it and the days are numbered for how shares could ever possibly, could be transitioned..

I'll be holding onto every possible share I can, because its a matter of time and I remind myself daily of all the possibilities and need one of those dia76ca reminders of what is to come on just the medical front. I think the "astronomical" value is derived from that of course.... but also from many other areas.

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News